Literature DB >> 33350435

Optimization of the isolation procedure and culturing conditions for hepatic stellate cells obtained from mouse.

Thanh Minh Dang1,2,3, Trinh Van Le1,2, Huy Quang Do1,2, Van Thuan Nguyen2,3, Ai Xuan Le Holterman4, Loan Tung Thi Dang2,5, Nhan Chinh Lu Phan2,6, Phuc Van Pham1,2, Son Nghia Hoang7, Long Thanh Le7, Gabriele Grassi8, Nhung Hai Truong1,2,5.   

Abstract

Liver fibrosis (LF) mortality rate is approximately 2 million per year. Irrespective of the etiology of LF, a key element in its development is the transition of hepatic stellate cells (HSCs) from a quiescent phenotype to a myofibroblast-like cell with the production of fibrotic proteins. It is necessary to define optimal isolation and culturing conditions for good HSCs yield and proper phenotype preservation for studying the activation of HSCs in vitro. In the present study, the optimal conditions of HSC isolation and culture were examined to maintain the HSC's undifferentiated phenotype. HSCs were isolated from Balb/c mice liver using Nycodenz, 8, 9.6, and 11%. The efficiency of the isolation procedure was evaluated by cell counting and purity determination by flow cytometry. Quiescent HSCs were cultured in test media supplemented with different combinations of fetal bovine serum (FBS), glutamine (GLN), vitamin A (vitA), insulin, and glucose. The cells were assessed at days 3 and 7 of culture by evaluating the morphology, proliferation using cell counting kit-8, lipid storage using Oil Red O (ORO) staining, expression of a-smooth muscle actin, collagen I, and lecithin-retinol acyltransferase by qRT-PCR and immunocytochemistry (ICC). The results showed that Nycodenz, at 9.6%, yielded the best purity and quantity of HSCs. Maintenance of HSC undifferentiated phenotype was achieved optimizing culturing conditions (serum-free Dulbecco's Modified Eagle's Medium (DMEM) supplemented with glucose (100 mg/dl), GLN (0.5 mM), vitA (100 μM), and insulin (50 ng/ml)) with a certain degree of proliferation allowing their perpetuation in culture. In conclusion, we have defined optimal conditions for HSCs isolation and culture.
© 2021 The Author(s).

Entities:  

Keywords:  HSCs activation; Hepatic Stellate Cells; Nycodenz; Quiescent stellate cells; liver fibrosis

Mesh:

Substances:

Year:  2021        PMID: 33350435      PMCID: PMC7823195          DOI: 10.1042/BSR20202514

Source DB:  PubMed          Journal:  Biosci Rep        ISSN: 0144-8463            Impact factor:   3.840


  43 in total

1.  A simple method for the simultaneous isolation of stellate cells and hepatocytes from rat liver tissue.

Authors:  Lisa Riccalton-Banks; Rena Bhandari; Jeffrey Fry; Kevin M Shakesheff
Journal:  Mol Cell Biochem       Date:  2003-06       Impact factor: 3.396

Review 2.  Update on hepatic stellate cells: pathogenic role in liver fibrosis and novel isolation techniques.

Authors:  Frank Tacke; Ralf Weiskirchen
Journal:  Expert Rev Gastroenterol Hepatol       Date:  2012-02       Impact factor: 3.869

3.  Identification and functional characterization of the hepatic stellate cell CD38 cell surface molecule.

Authors:  Sandra March; Mariona Graupera; María Rosa Sarrias; Francisco Lozano; Pilar Pizcueta; Jaume Bosch; Pablo Engel
Journal:  Am J Pathol       Date:  2007-01       Impact factor: 4.307

Review 4.  Seminars in medicine of the Beth Israel Hospital, Boston. The cellular basis of hepatic fibrosis. Mechanisms and treatment strategies.

Authors:  S L Friedman
Journal:  N Engl J Med       Date:  1993-06-24       Impact factor: 91.245

5.  Isolation and culture of hepatic stellate cells from mouse liver.

Authors:  Wenju Chang; Mengxuan Yang; Lujun Song; Kuntang Shen; Hongshan Wang; Xiaodong Gao; Min Li; Weixin Niu; Xinyu Qin
Journal:  Acta Biochim Biophys Sin (Shanghai)       Date:  2014-01-03       Impact factor: 3.848

6.  High glucose stimulates hepatic stellate cells to proliferate and to produce collagen through free radical production and activation of mitogen-activated protein kinase.

Authors:  Rie Sugimoto; Munechika Enjoji; Motoyuki Kohjima; Satoshi Tsuruta; Marie Fukushima; Masataka Iwao; Toshiyo Sonta; Kazuhiro Kotoh; Toyoshi Inoguchi; Makoto Nakamuta
Journal:  Liver Int       Date:  2005-10       Impact factor: 5.828

7.  Comparison of glial fibrillary acidic protein and desmin staining in normal and CCl4-induced fibrotic rat livers.

Authors:  T Niki; P J De Bleser; G Xu; K Van Den Berg; E Wisse; A Geerts
Journal:  Hepatology       Date:  1996-06       Impact factor: 17.425

8.  Hepatic Stellate Cells Inhibit T Cells through Active TGF-β1 from a Cell Surface-Bound Latent TGF-β1/GARP Complex.

Authors:  Yan Li; Byung-Gyu Kim; Shiguang Qian; John J Letterio; John J Fung; Lina Lu; Feng Lin
Journal:  J Immunol       Date:  2015-08-05       Impact factor: 5.422

9.  Colocalization of three types of intermediate filament proteins in perisinusoidal stellate cells: glial fibrillary acidic protein as a new cellular marker.

Authors:  G Buniatian; R Gebhardt; D Schrenk; B Hamprecht
Journal:  Eur J Cell Biol       Date:  1996-05       Impact factor: 4.492

Review 10.  Hepatic stellate cell lipid droplets: a specialized lipid droplet for retinoid storage.

Authors:  William S Blaner; Sheila M O'Byrne; Nuttaporn Wongsiriroj; Johannes Kluwe; Diana M D'Ambrosio; Hongfeng Jiang; Robert F Schwabe; Elizabeth M C Hillman; Roseann Piantedosi; Jenny Libien
Journal:  Biochim Biophys Acta       Date:  2008-11-24
View more
  2 in total

1.  Academic Pediatric Surgery Capacity Building in Vietnam Through PASS, a Pediatric Acute Surgical Support Course.

Authors:  Bich-Uyen Nguyen; Aixuan Holterman; Mark Holterman; Le-Thanh Dinh
Journal:  Front Surg       Date:  2022-04-20

2.  KIAA1363 affects retinyl ester turnover in cultured murine and human hepatic stellate cells.

Authors:  Carina Wagner; Victoria Hois; Annalena Eggeling; Lisa-Maria Pusch; Laura Pajed; Patrick Starlinger; Thierry Claudel; Michael Trauner; Robert Zimmermann; Ulrike Taschler; Achim Lass
Journal:  J Lipid Res       Date:  2022-01-29       Impact factor: 5.922

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.